medigraphic.com

2003, Number 2

<< Back Next >>

Rev Fac Med UNAM 2003; 46 (2)

Mid-line destructive syndrome.

Valdez L, Andrade V, Nellen H, Halabe J

Language: Spanish
References: 52
Page: 59-62
PDF size: 41.06 Kb.


ABSTRACT

Several diseases can affect the mid-line structures of the face making it difficult to stablish comparisons and descriptions. This paper’s aim is to offer a resume of published information. A number of denominations have been used: mid-line granulomatosis, gangrescens granuloma, medio-facial destructive disease, and others. None seems to be the best acceptable since there are wide variations in etiology, extensions and prognosis. This is the reason why some years ago the name of mid-line destructive syndrome was proposed.


REFERENCES

  1. Wolff S. Granuloma de la línea media. En: Harrison Principios de Medicina Interna. Interamericana-McGraw-Hill, 13ª ed, 1994; pp 1940-1942.

  2. Sandoval RT, Castañón GJ, Halabe ChJ, Laredo SF, Lifshitz A. Enfoque clínico del síndrome destructivo de la línea media. Rev Med IMSS 1988; 26: 235-39.

  3. Gimenez A. Granuloma de la línea media. Actualidad Dermatológica. 1995; 34: 231-236.

  4. Robinson A, Frase I, Bailey D, O´Halloran MJ. Idiopathic midline destructive disease-case report and review of the literature. Postgraduate Medical Journal, 1984; 60: 471-473.

  5. Vilde JL, Perrone MD, Huchon MD et al. Association of Epstein-Barr virus letal with letal midline granuloma. NEJM, 1985; 313: 1161.

  6. Harabuchi Y, Yamanaka N. Epstein-Barr virus in nasal T cell lymphomas in patients with letal midline granuloma. Lancet, 1990; 335: 128-30.

  7. Mishima K, Horiuchi K, Koyja S, et al. Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan. Cancer, 1994; 73: 3041-3046.

  8. Romwedder JJ. Upper respiratory tract tuberculosis-sixteen cases in a general hospital. Ann Intern Med, 1974; 80: 708-713.

  9. Weese WC, Smith IM. A study of 57 cases of actinomycosis over a 36 years period. Arch Int Med, 1975; 135: 1562-1568.

  10. Real Mora O, Zamora QJ, Abud MC, et al. Mucormicosis, informe de 14 casos. Rev Invest Clin 1983; 35: 237-240.

  11. England A, Weinstein M, Ellner JM. Two cases of rhinocerebral zygomycosis with common epidemiologic and environmental features. Am Rev Resp Dis, 1981; 124: 497-498.

  12. Jackler R, Kaplan M. Ear, nose and throat. In: Current, medical diagnosis and treatment. Mc Graw-Hill, 2001, pp 235.

  13. Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am, 2000; 33: 349-65.

  14. Alvarado F, Ibarra D, Issibasi A, Kumate J. Candidiasis mucocutánea crónica grave. Infectología, 1974; 80: 310-320.

  15. Samuel J, Wolf L. Oto-laryngeal histoplasmosis, 1986; 100: 179-185.

  16. Bennett DE. Histoplasmosis of the oral cavity and larynx. Arch Inter Med, 1967; 120: 417-427.

  17. Calcaterra TC. Otolaryngeal histoplasmosis. Laryngoscope, 1970; 80: 111-120.

  18. Krishnan MM, Kawatra VK, Ratnakar C. Diverticulum of the lacrimal sac associated with rhinosporidiosis. Br J Ophthalmology, 1986; 79: 867-868.

  19. Golhman M. Rhinoscleroromo snd rhinosporidiosis and approach through history. Int J Dermatology, 1986; 25: 476-478.

  20. Jiménez JF, Young DE, Hough A. Rhinosporidiosis, a report of two cases from Arkansas. Am J Clin Pathol, 1984; 82: 611-615.

  21. Siberry G, Costarangos C, Cohen B. Destruction of the nasal septum by aspergillus infection after autologous bone marrow transplantation. NEJM, 1997; 337: 275-276.

  22. Khachemoune A. Chronic ulcerative lesion of the face. Am Fam Physician, 2001; 64: 1883-84.

  23. Lemons E. Unusual cutaneous infectious and parasitic disease. Dermatol Clin, 1999; 17: 151-85.

  24. Tigges G. Nasal T-cell lymphoma as a differential diagnosis of the midline granuloma syndrome. Laryngorhinootologie, 1999; 78: 139-143.

  25. Rodríguez W. Tumores malignos mesenquimales de cavidad oral. En Neoplasias malignas de cabeza y cuello. Fondo editorial UNMSM, 2000.

  26. Chott A, Rappersberger K, Schlossarek, et al. Peripheral T cell lymphoma presenting primary as lethal midline granuloma. Hum Pathol, 1988; 19: 1093-1101.

  27. Platt JC, Tomich CE, Campbell S. Malignant lymphoma presenting as a midline granuloma. J Oral Maxillofac Surg, 1989; 47: 511-513.

  28. Suzumiya J. Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene. Leuc Lymphoma, 1999; 35: 567-78.

  29. OhsawaM. Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology .Int J Cancer 1999; 81: 865-70.

  30. Dilhuydy MS. Natural killer cell nasal lymphoma mimicking localized Wegener´s disease. Rev Med Intern, 2001; 22: 571-5.

  31. Chim CS. Lethal midline granuloma revised: nasal T/Natural killer cell lymphoma. J Clin Oncol, 1999; 17: 1322-5.

  32. Ullrich D. Nasal T cell lymphoma of the lethal midline type. Case report and current aspects in the literature. HNO, 1999; 47: 490-3.

  33. Kirakawa S. Nasal and nasal type natural killer/T cell lymphoma J Am Acad Dermatol, 1999; 40: 268-72.

  34. Sueldo-Rivero E. Manifestaciones orales de neoplasias malignas. Dermatología Peruana, 2001; 11.

  35. Kojya S, Itokazu T. Lethal midline Granuloma in Okinawa with special emphasis on polymorphic reticulosis. Japanese Journal of Cancer Research, 1994; 85: 384-88.

  36. Mann WJ, Riede UN, Bocking A. Midline malignant reticulosis. Arch Otolaryng, 1984; 97: 365-372.

  37. Fechner RE, Lamppin DW. Midline malignant reticulosis. Arch Otolaryng, 1972: 467-476.

  38. McDonald T, Remee RA, Wekand LH. Wegener´s granulomatosis and polimorphic reticulosis: two diseases or one?. Arch Otolaryngol, 1981; 107: 141-144.

  39. Batsakis J. Wegener´s granulomatosis and midline granuloma. Head and Neck Surgery, 1979; 1: 213.

  40. Gaulard P, Henni T, Marolleau JP, et al. Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence for monoclonal T. cell lymphoproliferative disorder. Cancer, 1988; 62: 705-710.

  41. Laeng H, Gerber H, Mueller J. Malignant histiocytosis (histiocytic sarcoma) A major cause of the midline granuloma syndrome. Acta Otolaryngol., 1986; 101: 135-145.

  42. Sercauz J, Stransnick B, Newman A, Dood L. Midline nasal destruction in cocaine abusers. Otolaryngology Head and Neck Surgery, 1991; 105: 694-701.

  43. Trimarchi M, Gregorini G, Facchetti F, et al. Cocine-induced midline destructive lesions: clinical, radiographic, histopathologic, and serologic features and their differentiations from Wegener granulomatosis. Medicine, 2001; 80: 391.

  44. Rasmussen N. Management of the ear, nose and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist´s perspective.Curr Opin Rheumatol 2001; 13: 3-11.

  45. Ruey-Bin C, Nagase M.Treatment of Idiopathic midline destructive disease by irradiation. A case report. J Craniomaxillofac Surg 1988; 16: 375-8.

  46. Sánchez Fernández JM. Midline granuloma syndrome. A Clinic and pathological report of four patients. Acta Otolaryngol. 1987; 103: 441-7.

  47. Harrison DE. Midline destructive Granuloma: fact or fiction. Laryngoscope 1987; 97: 1049-53.

  48. O’Connor JC, Robinson RA. Review of Diseases presenting as midline granuloma. Clinical implications for the appropiate workup of patients with midline granuloma syndrome with emphasis on recent diagnosis advances in lymphoid neoplasms that present as midline destructive lesions. Acta Otolaryngol Suppl 1987; 439: 1-16.

  49. Barker TH, Path FR. Idiopathic midline destructive disease-does it exist? The Journal of Laryngology and Otology, 1998; 112: 307-9.

  50. Lu SY. Lethal midline granuloma: report of three cases. Chang Keng I Hsueh Tsa Chih, 2000; 23: 99-106.

  51. Borges A. Midline destructive lesions of the sinonasal tract: simplified terminology based on histopathologic criteria. AJNR Am J Neuroradiol, 2000; 21: 331-336.

  52. Torre V. Midfacial granuloma syndrome or an inflammatory non-specific disease? A case report. J Oral Pathol Med 2001; 30: 190-192.




2020     |     www.medigraphic.com